Skip to content

Clinical trials

Breast Neoplasms trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Austria Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20022
20034
20048
20059
200610
200714
20088
20096
20108
20118
201210
20139
201412
201514
20166
20176
20186
20199
20209
202112
20226
202312
20245
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed124
Active, not recruiting33
Terminated27
Recruiting19
Unknown status8
Withdrawn4
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche25
Novartis Pharmaceuticals20
AstraZeneca18
Eli Lilly and Company10
Medical University of Vienna8
Amgen6
Arbeitsgemeinschaft medikamentoese Tumortherapie6
Austrian Breast & Colorectal Cancer Study Group6
GlaxoSmithKline6
Sanofi6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms216
Neoplasm Metastasis22
Neoplasms15
Lung Neoplasms8
Brain Neoplasms7
Colorectal Neoplasms6
Triple Negative Breast Neoplasms6
Breast Diseases5
Ovarian Neoplasms5
Prostatic Neoplasms5

Trials

Showing 26 to 50 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.